SCHEMBL8237356

SCHEMBL8237356

CCSC=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3626634 0.67
SCHEMBL1937161 0.67
SCHEMBL3626632 0.67
SCHEMBL12240236 0.65
SCHEMBL385580 0.61
SCHEMBL3462354 0.61
SCHEMBL6037527 0.61
SCHEMBL2244165 0.61
SCHEMBL2990789 0.61
SCHEMBL575742 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968274-A1 MEROPENEM DERIVATIVES AND USES THEREOF Kala Pharmaceuticals, Inc. (US) 2016-01-20 EP disclosed
WO-2014144285-A1 MEROPENEM DERIVATIVES AND USES THEREOF KALA PHARMACEUTICALS, INC. (US) 2014-09-18 WO disclosed
EP-2540846-A2 Process for precious metal recovery from a sulphide ore or concentrate or other feed material CESL Limited (CA) 2013-01-02 EP disclosed
US-20090256468-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-10-15 US disclosed
EP-2096108-A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same Gracel Display Inc. (KR) 2009-09-02 EP disclosed
WO-2007015824-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2007-02-08 WO disclosed